Real-time enrollment status for this non hodgkin's lymphoma refractory/relapsed clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 8:08 PM UTC
| NCT Number | NCT05618925 |
| Recruiting Status | Recruiting |
| Condition | Non Hodgkin's Lymphoma Refractory/Relapsed |
| Phase | PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 2 sites in the US |
| Sponsor | ImmunityBio, Inc. |
| Last Updated on CT.gov | April 1, 2026 (Apr 1, 2026) |
As of July 18, 2026: Clinical trial NCT05618925 is currently recruiting participants. This phase1 study for non hodgkin's lymphoma refractory/relapsed is actively seeking new participants at 2 locations across the United States. The study is sponsored by ImmunityBio, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05618925 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05618925 was last updated Apr 1, 2026 (April 1, 2026). HelloStudys verifies this status automatically.